A. C. Hager

Single framework recombinant antibody fragments designed for protein chip applications.

C. Borrebaeck, C. Steinhauer, C. Wingren, 2002, BioTechniques.

Affinity and Epitope Profiling of Mouse Anti‐CD40 Monoclonal Antibodies

C. Borrebaeck, P. Ellmark, A. C. Hager, 2003, Scandinavian journal of immunology.

Development of Interleukin-1 Receptor Antagonist Mutants with Enhanced Antagonistic Activity In Vitro and Improved Therapeutic Efficacy in Collagen-Induced Arthritis

L. Joosten, W. B. van den Berg, M. Andersson, 2008, Journal of immunotoxicology.

Protein Chips Based on Recombinant Antibody Fragments

S. Ekström, G. Marko‐Varga, T. Laurell, 2001 .

Genetic signature of prostate cancer resistant to optimized hK2 targeted alpha-particle therapy

S. Larson, R. Klein, M. Morris, 2019, bioRxiv.

Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down‐regulating fibrinolysis

P. Cronet, H. Stenhamre, Anna Harrysson, 2006, The FEBS journal.

Protein chips based on recombinant antibody fragments: a highly sensitive approach as detected by mass spectrometry.

S. Ekström, G. Marko‐Varga, T. Laurell, 2001, BioTechniques.